Company intelligence / Profile preview

Proton International

Alpharetta, Georgia, United States

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Proton International develops and operates proton therapy centers that deliver commercially available proton beam therapy for cancer patients. These centers are fully operational, treating patients with established, peer-reviewed efficacy in reducing collateral tissue damage and improving outcomes over traditional X-ray radiotherapy in selected cancers.

Therapeutic areas: Oncology
Modalities: DeviceNon-pharmacological therapyRadiotherapy (proton beam)
Industry: Therapeutic Medical Devices

Partnerships

Mevion Medical SystemsVarian Medical Systems

Beyond the preview

Go deeper on Proton International.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Proton International.

Explore the full profile